MARKET

SGHT

SGHT

Sight Sciences, Inc.
NASDAQ
3.280
-0.140
-4.09%
After Hours: 3.280 0 0.00% 16:20 05/14 EDT
OPEN
3.420
PREV CLOSE
3.420
HIGH
3.650
LOW
3.280
VOLUME
171.09K
TURNOVER
--
52 WEEK HIGH
8.45
52 WEEK LOW
2.030
MARKET CAP
169.58M
P/E (TTM)
-3.3603
1D
5D
1M
3M
1Y
5Y
1D
Sight Sciences, Inc. (NASDAQ:SGHT) Surges 44% Yet Its Low P/S Is No Reason For Excitement
Simply Wall St · 14h ago
Weekly Report: what happened at SGHT last week (0505-0509)?
Weekly Report · 2d ago
Sight Sciences First Quarter 2025 Earnings: Beats Expectations
Simply Wall St · 4d ago
Sight Sciences, Inc. Earnings Call: Mixed Results and Strategic Focus
TipRanks · 5d ago
Piper Sandler Sticks to Its Hold Rating for Sight Sciences (SGHT)
TipRanks · 5d ago
Sight Sciences Is Maintained at Hold by Lake Street
Dow Jones · 5d ago
Lake Street Maintains Hold on Sight Sciences, Raises Price Target to $3
Benzinga · 5d ago
Sight Sciences (SGHT) Gets a Buy from Stifel Nicolaus
TipRanks · 5d ago
More
About SGHT
More
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Recently
Symbol
Price
%Change
    UA
  • 6.00
  • +0.17%

Webull offers Sight Sciences Inc stock information, including NASDAQ: SGHT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGHT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGHT stock methods without spending real money on the virtual paper trading platform.